South Africa’s participation in the vaccine procurement mechanism, COVAX, is finally confirmed – but the details of a vaccine rollout plan for the country are still lacking. Such a strategy will, among other things, guide us as to who will receive Covid-19 jabs first. As an upper middle-income country, we will have COVAX’s help to secure vaccine doses from pooled supplies, but South Africa would have to finance the actual purchases itself. The Solidarity Fund – a private fund set up in South Africa to raise money from the private sector and individuals, to supplement funding for Covid-19-related initiatives – has agreed to make an initial payment of R327-million ($22-million) to COVAX to secure vaccines for about 10% of our population.